Source: Eur Respir J, 56 (5) 2000075; 10.1183/13993003.00075-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ashley R. Rackow, David J. Nagel, Claire McCarthy, Jennifer Judge, Shannon Lacy, Margaret A.T. Freeberg, Thomas H. Thatcher, R. Matthew Kottmann, Patricia J. Sime. The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops. Eur Respir J, 56 (5) 2000075; 10.1183/13993003.00075-2020

Member's Comments

No comment yet.

Related content which might interest you: Shared pathways of lung development and misled repair during pulmonary fibrosis Source: International Congress 2015 – IPF: an airway-derived disease? Year: 2015 Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019 Year: 2020 Blocking endothelin: breaking new ground Source: Eur Respir Rev 2008; 17: 24-29 Year: 2007 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)? Source: Eur Respir J 2007; 30: Suppl. 51, 578s Year: 2007 LSC 2011 Abstract: Histological markers of epithelial-mesenchymal transition in idiopathic pulmonary fibrosis provide evidence of an alternative repair process Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018 Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 519-521 Year: 2012 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 The progressive fibrotic phenotype in fibrotic ILDs: the critical importance of observed disease behaviour Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019 The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! Source: Eur Respir J, 53 (3) 1900038; 10.1183/13993003.00038-2019 Year: 2019 Classifying interstitial lung diseases in a fractal lung: a morphologist's view "anno Domini 2000" Source: Eur Respir J 2001; 18: 107S-113S Year: 2001 Personalised pathogenetic pathways in fibrotic ILDs: the yin of pathogenetic thinking Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019 Silent microaspiration in idiopathic pulmonary fibrosis: The role of videolaryngoscopy Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016 Year: 2017 A role for the mesothelium in restrictive chronic lung allograft dysfunction? Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007